Breaking News, Collaborations & Alliances

OBiO Technology Adds Univercells Upstream Platform for Gene Therapy Mfg.

Agreement combines the capacity and capabilities of OBiO process development scientists with enabling platforms and support from Univercells Technologies.

OBiO Technology Corp., a gene and cell therapy CDMO in China, and Univercells Technologies, a provider of biomanufacturing technologies for flexible and scalable advanced therapies and vaccine production, entered into a strategic agreement to deploy novel technologies in Shanghai. The NevoLine Upstream biomanufacturing platform with scale-X bioreactors will now be offered in OBiO’s recently expanded GMP Shanghai facility to accelerate gene therapy manufacturing. The strategic agreement com...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters